IL6 and neoplasm: CRC murine models bearing IL-6-secreting iCAFs with constitutive STAT3 activation exhibited reduced tumor growth after inhibition of angiogenic signaling, suggesting that sustained angiogenesis at least partially depends on IL-6 and STAT3 signaling [37].